NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $9,000 | -52.6% | 7,374 | 0.0% | 0.00% | – |
Q1 2019 | $19,000 | +58.3% | 7,374 | 0.0% | 0.00% | – |
Q4 2018 | $12,000 | -29.4% | 7,374 | +106.3% | 0.00% | – |
Q3 2018 | $17,000 | -22.7% | 3,575 | 0.0% | 0.00% | – |
Q2 2018 | $22,000 | -43.6% | 3,575 | -24.9% | 0.00% | – |
Q1 2018 | $39,000 | -37.1% | 4,758 | -21.4% | 0.00% | – |
Q4 2017 | $62,000 | +17.0% | 6,051 | +3.0% | 0.00% | – |
Q3 2017 | $53,000 | +65.6% | 5,876 | +29.9% | 0.00% | – |
Q2 2017 | $32,000 | -3.0% | 4,523 | 0.0% | 0.00% | – |
Q1 2017 | $33,000 | +57.1% | 4,523 | +35.9% | 0.00% | – |
Q4 2016 | $21,000 | +61.5% | 3,327 | +64.1% | 0.00% | – |
Q3 2016 | $13,000 | -27.8% | 2,027 | 0.0% | 0.00% | – |
Q2 2016 | $18,000 | – | 2,027 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 1,043,770 | $7,620,000 | 2.51% |
Stonepine Capital Management, LLC | 565,100 | $4,125,000 | 2.23% |
DAFNA Capital Management LLC | 209,873 | $1,532,000 | 1.09% |
Ghost Tree Capital, LLC | 500,000 | $3,650,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,459,195 | $10,652,000 | 0.57% |
PURA VIDA INVESTMENTS, LLC | 150,000 | $1,095,000 | 0.44% |
J. Goldman & Co LP | 845,000 | $6,169,000 | 0.33% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 191,729 | $1,400,000 | 0.20% |
Opaleye Management Inc. | 50,000 | $365,000 | 0.15% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 50,000 | $365,000 | 0.15% |